FR2536281B1 - Compositions pharmaceutiques permettant de reguler les fonctions phagocytaires - Google Patents

Compositions pharmaceutiques permettant de reguler les fonctions phagocytaires

Info

Publication number
FR2536281B1
FR2536281B1 FR838318502A FR8318502A FR2536281B1 FR 2536281 B1 FR2536281 B1 FR 2536281B1 FR 838318502 A FR838318502 A FR 838318502A FR 8318502 A FR8318502 A FR 8318502A FR 2536281 B1 FR2536281 B1 FR 2536281B1
Authority
FR
France
Prior art keywords
phagocytaic
regulating
functions
pharmaceutical compositions
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR838318502A
Other languages
English (en)
French (fr)
Other versions
FR2536281A1 (fr
Inventor
Haruo Ohnishi
Hiroshi Kosuzume
Yasuo Suzuki
Ei Mochida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mochida Pharmaceutical Co Ltd
Original Assignee
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharmaceutical Co Ltd filed Critical Mochida Pharmaceutical Co Ltd
Publication of FR2536281A1 publication Critical patent/FR2536281A1/fr
Application granted granted Critical
Publication of FR2536281B1 publication Critical patent/FR2536281B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/488—Aspartic endopeptidases (3.4.23), e.g. pepsin, chymosin, renin, cathepsin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR838318502A 1982-11-20 1983-11-21 Compositions pharmaceutiques permettant de reguler les fonctions phagocytaires Expired FR2536281B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57203990A JPS5995221A (ja) 1982-11-20 1982-11-20 食細胞機能調節作用を有する医薬組成物

Publications (2)

Publication Number Publication Date
FR2536281A1 FR2536281A1 (fr) 1984-05-25
FR2536281B1 true FR2536281B1 (fr) 1989-05-12

Family

ID=16482949

Family Applications (1)

Application Number Title Priority Date Filing Date
FR838318502A Expired FR2536281B1 (fr) 1982-11-20 1983-11-21 Compositions pharmaceutiques permettant de reguler les fonctions phagocytaires

Country Status (11)

Country Link
US (1) US4534966A (US08197722-20120612-C00042.png)
JP (1) JPS5995221A (US08197722-20120612-C00042.png)
AU (1) AU552756B2 (US08197722-20120612-C00042.png)
CA (1) CA1204054A (US08197722-20120612-C00042.png)
CH (1) CH657050A5 (US08197722-20120612-C00042.png)
DE (1) DE3341760A1 (US08197722-20120612-C00042.png)
FR (1) FR2536281B1 (US08197722-20120612-C00042.png)
GB (1) GB2132481B (US08197722-20120612-C00042.png)
IT (1) IT1174799B (US08197722-20120612-C00042.png)
NL (1) NL8303980A (US08197722-20120612-C00042.png)
SE (1) SE460825B (US08197722-20120612-C00042.png)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8309072B2 (en) * 2004-11-12 2012-11-13 The Zhabilov Trust Irreversibly-inactivated pepsinogen fragments for modulating immune function
US8067531B2 (en) 2004-11-12 2011-11-29 The Zhabilov Trust Inactivated pepsin fragments for modulating immune system activity against human malignant tumor cells
WO2007041285A2 (en) * 2005-09-29 2007-04-12 Viral Genetics, Inc. Complexes of inactivated pepsin fraction and heat shock protein

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR59346E (fr) * 1949-06-09 1954-05-24 Valise roulante
US2930736A (en) * 1957-01-07 1960-03-29 Nat Drug Co Stabilized trypsin compositions containing partially hydrolyzed gelatin and method of making
FR2119872A1 (fr) * 1970-12-30 1972-08-11 Kuban Med I Im Krasnoi Armii Produit a base de pepsine,notamment pour le traitement des maladies s'accompagnant d'une insuffisance secretoire de l'estomac
US4272522A (en) * 1979-10-15 1981-06-09 Balazs Endre A Method for stimulating phagocytic activity and synergistic compositions therefor
CA1181005A (en) * 1981-02-10 1985-01-15 Haruo Ohnishi Therapeutic agent for treatment of allergic diseases, immune complex diseases and tumors
NL8220027A (nl) * 1982-02-09 1983-11-01 Mochida Pharm Co Ltd Therapeutisch middel voor de behandeling van allergische aandoeningen, immuno.complexziekten en tumoren.
AU8459882A (en) * 1982-05-31 1983-12-16 Mochida Pharmaceutical Co., Ltd. Human leukocyte pepsin-like enzyme, and a therapeutic agent containing said enzyme as effective ingredient for treating allergic disorder, immune complex disease, and tumor

Also Published As

Publication number Publication date
IT1174799B (it) 1987-07-01
AU552756B2 (en) 1986-06-19
CA1204054A (en) 1986-05-06
AU2155483A (en) 1984-05-24
CH657050A5 (de) 1986-08-15
SE460825B (sv) 1989-11-27
JPH0261925B2 (US08197722-20120612-C00042.png) 1990-12-21
GB2132481A (en) 1984-07-11
DE3341760C2 (US08197722-20120612-C00042.png) 1989-09-07
JPS5995221A (ja) 1984-06-01
GB2132481B (en) 1987-02-11
US4534966A (en) 1985-08-13
IT8349367A0 (it) 1983-11-21
SE8306384L (sv) 1984-05-21
GB8330810D0 (en) 1983-12-29
DE3341760A1 (de) 1984-06-14
SE8306384D0 (sv) 1983-11-18
NL8303980A (nl) 1984-06-18
FR2536281A1 (fr) 1984-05-25

Similar Documents

Publication Publication Date Title
FR2547727B1 (fr) Compositions pharmaceutiques
NO831186L (no) Fortilsetning for droevtyggere
IT1193628B (it) Sistema emulsionante per composizioni cosmetiche
IT1169771B (it) Composizione per agenti antitumorali
IT1162879B (it) Composizioni farmaceutiche
ZA821028B (en) Pharmaceutical compositions for implantation
FR2536281B1 (fr) Compositions pharmaceutiques permettant de reguler les fonctions phagocytaires
BE896711A (fr) Compositions pharmaceutiques anti-ulceres.
FI831536L (fi) Styranordning foer hydrauliska pressar
FI832416L (fi) Aetbar emulsion med foerbaettrad mikrobiologisk stabilitet
DK567683D0 (da) Dyrefodersammensaetninger
DK206383D0 (da) Aldosteronderivater
NO821786L (no) Halekonstruksjon for overflateeffektfartoey
FI831814A0 (fi) Anordning foer bearbetning av traedbark
FR2536102B1 (fr) Parpaing pour construction
FR2531065B1 (fr) Materiau epais de platrage
BR8304566A (pt) Composicao herbecida sinergistica
FI830485L (fi) Anordning foer taeckning av en lastbehaollare
DK161484A (da) Vitamin d analoge forbindelser
BR8106908A (pt) Composicoes especialmente para o desfolhamento de plantas
JPS56129653A (en) Emulsion composition for mortar
SE8200618L (sv) Komposition for tremodifiering
KR830001322U (ko) 세곡용바가지
RO85684A2 (ro) Compozitie dezemailanta
IT1152486B (it) Composizione farmaceutica antiateromasica

Legal Events

Date Code Title Description
ST Notification of lapse